FARAPULSE provides tissue-selective PFA therapy through development and commercialization of its dedicated generator (FARASTAR), PVI-focused catheter (FARAWAVE), large-area focal catheter (FARAFLEX), precision focal catheter (FARAPOINT) and a proprietary deflectable delivery sheath (FARADRIVE).

Register for Details

For more details on financing and valuation for Farapulse, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Farapulse

Forge green plus iconForge green minus icon

What is Farapulse funding to date?

Farapulse has raised $80.75MM to date.
Forge green plus iconForge green minus icon

When was Farapulse founded?

Farapulse was founded in 1900.
Updated on: Jun 12, 2022